Related Articles
Silencing IDO2 in dendritic cells: A novel strategy to strengthen cancer immunotherapy in a murine lung cancer model
IDO inhibitor synergized with radiotherapy to delay tumor growth by reversing T cell exhaustion
Whole-cell vaccine coated with recombinant calreticulin enhances activation of dendritic cells and induces tumour-specific immune responses
Dendritic cell vaccine immunotherapy of cancer targeting MUC1 mucin
Immunoactivative role of indoleamine 2,3‑dioxygenase in gastric cancer cells in vitro